Raia Drogasil (RADLY) Stock Price, News & Analysis

Company Overview

Raia Drogasil S.A. is a leading Brazilian retail pharmacy operator, offering a comprehensive range of prescription and over-the-counter medications, health and wellness products, personal care and beauty items, as well as a selection of convenience goods. The company’s network of stores operates under the Raia and Drogasil banners, serving diverse consumer needs across major urban centers. Complementary services include in-store prescription dispensing, compounding pharmacies and health screening programs such as blood pressure and glucose monitoring.

The company was formed in 2011 through the merger of two established Brazilian pharmacy chains, Drogasil and Droga Raia, each with origins dating back several decades. Headquartered in São Paulo, Raia Drogasil has expanded its footprint to all regions of Brazil, with a particularly strong presence in the Southeastern and Northeastern states. This broad geographic coverage positions the company to capture growth in densely populated metropolitan markets as well as emerging local communities.

In response to evolving consumer preferences, Raia Drogasil has developed digital platforms that support online ordering, home delivery and click-and-collect services. The company has also launched a loyalty program that rewards frequent shoppers with discounts, personalized promotions and health-oriented content. These initiatives complement its physical retail network, enhancing customer convenience and fostering deeper engagement.

Raia Drogasil continues to invest in supply chain optimization and partnerships with pharmaceutical and consumer goods suppliers to broaden its product portfolio. The company’s management emphasizes operational efficiency, store modernization and the integration of digital tools, aiming to reinforce its position as Brazil’s foremost pharmacy chain and to meet the evolving needs of Brazilian consumers.

Key Stats

• Today's Range: $3.41 to $3.41
• 50-Day Range: $2.30 to $3.65
• 52-Week Range: $2.21 to $5.30
• Volume: 3,802 shs
• Average Volume: 19,048 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

RADLY Stock Analysis - Frequently Asked Questions

How have RADLY shares performed this year?

Raia Drogasil's stock was trading at $3.25 at the beginning of 2025. Since then, RADLY shares have increased by 4.9% and is now trading at $3.4080.

When did Raia Drogasil's stock split?

Shares of Raia Drogasil split on the morning of Monday, May 22nd 2023.The 26-25 split was announced on Monday, May 22nd 2023. The newly created shares were distributed to shareholders after the closing bell on Monday, May 22nd 2023. An investor that had 100 shares of stock prior to the split would have 104 shares after the split.

How do I buy shares of Raia Drogasil?

Shares of RADLY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

• Today: 9/15/2025
• Next Earnings (Estimated): 11/03/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Pharmaceutical Retailers
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:RADLY
• CIK: N/A
• Web: www.rd.com.br
• Phone: 551137695678
• Fax: N/A
• Employees: 57,708
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A